Sarah has over 25 years' experience drafting, prosecuting and defending patents, primarily before the European Patent Office (EPO). She practises across a broad biotechnology subject matter base, including sequencing technology, genetics, gene delivery, vaccines, antibodies, diagnostic markers, personalised medicine, pharmaceutical formulation and dosage regimens and research tools, and mutant enzymes for cleantech applications.
A substantial amount of Sarah's work is for US companies and universities, both direct and through US attorney firms, prosecuting applications at the EPO and defending the resulting granted European patents in oppositions.
Her client base also includes UK universities and companies, and a number of Swedish companies. She has provided advice to many small and medium-sized companies, including filing strategies and portfolio reviews, drafting specifications, and coordinating and managing foreign filings.
Sarah is listed as an "IP Star" in the Managing Intellectual Property (MIP) IP Stars Handbook. She is also "recommended" in The Legal 500, IAM Patent 1000 and Who’s Who Legal: Patents.
Sarah joined J A Kemp in 1997, after working elsewhere in private practice since 1990, and became a partner at J A Kemp in 2002. She is also a member of the firm's management committee.
University of Cambridge, Masters Degree in Natural Sciences (Cellular and Genetic Pathology and Virology)
European Patent Attorney, UK Chartered Patent Attorney
Fellow of the Chartered Institute of Patent Attorneys (CIPA), Member of the Institute of Professional Representatives before the European Patent Office (EPI), Member of the UK BioIndustry Association (BIA) Intellectual Property Advisory Committee.